BACKGROUND. Malignant transformation is an infrequent but reported com
plication of endometriosis. Previous reports of these cases have been
limited to clinicopathologic studies based on routine histologic exami
nation of these tumors, whereas, to the authors' knowledge, characteri
zation of these lesions based on immunophenotype and hormone receptor
and oncoprotein expression has not been described. METHODS. Using comm
ercially available monoclonal antibodies, the authors studied three re
cent cases of adenocarcinoma arising in extragonadal endometriosis usi
ng paraffin immunohistochemistry. Proteins examined included different
cytokeratin (CK) subtypes, as well as hormone receptor status, prolif
eration rate, and oncoprotein expression. RESULTS. All three cases pre
sented clinically and macroscopically as colonic masses, and the tumor
s expressed an endometrial CK phenotype (CK7+, CK20-). In contrast, th
e adjacent benign colonic epithelium expressed the expected opposite p
henotype (CK7-, CK20+). Estrogen receptor (ER) and progesterone recept
or (PR) were expressed in one of the three tumors. Interestingly, in t
he ER/PR negative tumors, receptor expression was present in areas of
benign endometriosis adjacent to malignancy, suggesting a loss of rece
ptor expression with malignant transformation. The tumors also were ex
amined for proliferation by Ki-67, and the expression of oncoproteins
c-erb B-2, p53, cyclin D1, and bcl-2. AU cases of malignancy had a hig
h proliferation rate as measured by Ki-67, which was in contrast to ar
eas of benign endometriosis which had a low proliferation rate. Of the
other oncoproteins only p53 protein was detected at a significant lev
el in all three cases. Cyclin D1 was overexpressed in two of the three
cases. c-erb B2 and bcl-2 overexpression was not detected. CONCLUSION
S. The results of the current study 1) show the utility of CK subtypes
in confirming endometrioid phenotype in tumors arising in extragonada
l endometriosis with colonic involvement and 2) suggest that loss of h
ormone receptor expression and p53 oncoprotein abnormalities may be in
volved as mechanisms in malignant transformation in extragonadal endom
etriosis. (C) 1998 American Cancer Society.